Oxford Genome Sciences (UK) Ltd.
This article was originally published in Start Up
Executive Summary
The founders of Oxford Genome Sciences believe in the promise of personalized medicine, and are pursuing it directly-with assets and insights they say will enable the start-up to quickly achieve commercial goals. The company is intent on leveraging its OGAP database, which contains sequences of proteins from nearly a million human tissue samples, as well as human tumor cell lines and cerebrospinal fluid.